-
Something wrong with this record ?
Electroporation of germinated conidia and young mycelium as an efficient transformation system for Acremonium chrysogenum
J. Cruz-Ramón, FJ. Fernández, A. Mejía, F. Fierro,
Language English Country United States
Document type Comparative Study, Journal Article
Grant support
CB-2008-01 105527
CONACyT
203440
CONACyT
- MeSH
- Acremonium drug effects genetics metabolism MeSH
- Drug Resistance, Bacterial MeSH
- Cephalosporins biosynthesis MeSH
- Electroporation methods MeSH
- Phleomycins pharmacology MeSH
- Microbial Viability MeSH
- Mycelium drug effects genetics metabolism MeSH
- Protoplasts physiology MeSH
- Spores, Fungal drug effects genetics metabolism MeSH
- Transformation, Genetic * MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Three different transformation strategies were tested and compared in an attempt to facilitate and improve the genetic transformation of Acremonium chrysogenum, the exclusive producer of the pharmaceutically relevant β-lactam antibiotic cephalosporin C. We investigated the use of high-voltage electric pulse to transform germinated conidia and young mycelium and compared these procedures with traditional PEG-mediated protoplast transformation, using phleomycin resistance as selection marker in all cases. The effect of the field strength and capacitance on transformation frequency and cell viability was evaluated. The electroporation of germinated conidia and young mycelium was found to be appropriate for transforming A. chrysogenum with higher transformation efficiencies than those obtained with the conventional protoplast-based transformation procedures. The developed electroporation strategy is fast, simple to perform, and highly reproducible and avoids the use of chemicals toxic to cells. Electroporation of young mycelium represents an alternative method for transformation of fungal strains with reduced or no sporulation, as often occurs in laboratory-developed strains in the search for high-yielding mutants for industrial bioprocesses.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19021862
- 003
- CZ-PrNML
- 005
- 20190607120848.0
- 007
- ta
- 008
- 190607s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-018-0625-0 $2 doi
- 035 __
- $a (PubMed)29938299
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cruz-Ramón, Jessica $u Departamento de Biotecnología, Universidad Autónoma Metropolitana-Unidad Iztapalapa, Ciudad de México, Mexico.
- 245 10
- $a Electroporation of germinated conidia and young mycelium as an efficient transformation system for Acremonium chrysogenum / $c J. Cruz-Ramón, FJ. Fernández, A. Mejía, F. Fierro,
- 520 9_
- $a Three different transformation strategies were tested and compared in an attempt to facilitate and improve the genetic transformation of Acremonium chrysogenum, the exclusive producer of the pharmaceutically relevant β-lactam antibiotic cephalosporin C. We investigated the use of high-voltage electric pulse to transform germinated conidia and young mycelium and compared these procedures with traditional PEG-mediated protoplast transformation, using phleomycin resistance as selection marker in all cases. The effect of the field strength and capacitance on transformation frequency and cell viability was evaluated. The electroporation of germinated conidia and young mycelium was found to be appropriate for transforming A. chrysogenum with higher transformation efficiencies than those obtained with the conventional protoplast-based transformation procedures. The developed electroporation strategy is fast, simple to perform, and highly reproducible and avoids the use of chemicals toxic to cells. Electroporation of young mycelium represents an alternative method for transformation of fungal strains with reduced or no sporulation, as often occurs in laboratory-developed strains in the search for high-yielding mutants for industrial bioprocesses.
- 650 _2
- $a Acremonium $x účinky léků $x genetika $x metabolismus $7 D000164
- 650 _2
- $a cefalosporiny $x biosyntéza $7 D002511
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a elektroporace $x metody $7 D018274
- 650 _2
- $a mikrobiální viabilita $7 D050296
- 650 _2
- $a mycelium $x účinky léků $x genetika $x metabolismus $7 D025282
- 650 _2
- $a fleomyciny $x farmakologie $7 D010692
- 650 _2
- $a protoplasty $x fyziologie $7 D011523
- 650 _2
- $a spory hub $x účinky léků $x genetika $x metabolismus $7 D013172
- 650 12
- $a transformace genetická $7 D014170
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fernández, Francisco J $u Departamento de Biotecnología, Universidad Autónoma Metropolitana-Unidad Iztapalapa, Ciudad de México, Mexico.
- 700 1_
- $a Mejía, Armando $u Departamento de Biotecnología, Universidad Autónoma Metropolitana-Unidad Iztapalapa, Ciudad de México, Mexico.
- 700 1_
- $a Fierro, Francisco $u Departamento de Biotecnología, Universidad Autónoma Metropolitana-Unidad Iztapalapa, Ciudad de México, Mexico. fierrof@xanum.uam.mx.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 1 (2019), s. 33-39
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29938299 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190607 $b ABA008
- 991 __
- $a 20190607121026 $b ABA008
- 999 __
- $a ok $b bmc $g 1413052 $s 1060217
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 64 $c 1 $d 33-39 $e 20180625 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- GRA __
- $a CB-2008-01 105527 $p CONACyT
- GRA __
- $a 203440 $p CONACyT
- LZP __
- $a Pubmed-20190607